On November 1, 2017 Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for autoimmune diseases and cancer, reported that the company will present at two upcoming investor conferences in November (Press release, Alpine Immune Sciences, NOV 1, 2017, View Source [SID1234521449]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2017 Healthcare Conference
Tuesday, November 14, 2017, at 3:30 p.m. Eastern Time in New York.

29th Annual Piper Jaffray Healthcare Conference
Wednesday, November 29, 2017, at 10:50 a.m. Eastern Time in New York.

A live webcast of each presentation will be available online by visiting the investor relations page of the Company’s website, at View Source An archive of each webcast will be available on the Company’s website for 30 days.